Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTA) Gross Margin (2021 - 2025)

Historic Gross Margin for Strata Critical Medical (SRTA) over the last 5 years, with Q3 2025 value amounting to 23.56%.

  • Strata Critical Medical's Gross Margin rose 27400.0% to 23.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.2%, marking a year-over-year increase of 30100.0%. This contributed to the annual value of 23.69% for FY2024, which is 49900.0% up from last year.
  • Per Strata Critical Medical's latest filing, its Gross Margin stood at 23.56% for Q3 2025, which was up 27400.0% from 25.05% recorded in Q2 2025.
  • Strata Critical Medical's 5-year Gross Margin high stood at 25.05% for Q2 2025, and its period low was 10.98% during Q1 2022.
  • In the last 5 years, Strata Critical Medical's Gross Margin had a median value of 20.27% in 2022 and averaged 19.43%.
  • Its Gross Margin has fluctuated over the past 5 years, first plummeted by -86300bps in 2022, then skyrocketed by 70700bps in 2024.
  • Over the past 5 years, Strata Critical Medical's Gross Margin (Quarter) stood at 16.01% in 2021, then dropped by -19bps to 13.05% in 2022, then soared by 45bps to 18.98% in 2023, then skyrocketed by 31bps to 24.84% in 2024, then fell by -5bps to 23.56% in 2025.
  • Its Gross Margin stands at 23.56% for Q3 2025, versus 25.05% for Q2 2025 and 22.06% for Q1 2025.